juni 4, 2025
Lp(a) testing may improve CVC risk assessment in primary and secondary prevention settings
Figure is adapted from Nurmohamed et al. Eur J Prev Cardiol. 2022;29(5):769-776
Following Lp(a) testing
- One in three patients with very elevated Lp(a) levels* were reclassified into a higher primary prevention risk category
- 50% of all patients with very elevated Lp(a) levels* were reclassified into a higher seconday prevention risk category
SCORE: Conroy et al. Eur Heart J 2003;24:987–1003; https://www.heartscore.org/en_GB (Last accessed July 2024) SMART: Dorresteijn et al. Heart 2013;99:866–872; https://u-prevent.com/calculators/smartScore (Last accessed July 2024); *> 99th percentile, mean Lp(a) of 460 nmol/L.
SE250528_11435460